ATE440960T1 - T-helferzellen-epitope - Google Patents

T-helferzellen-epitope

Info

Publication number
ATE440960T1
ATE440960T1 AT00906047T AT00906047T ATE440960T1 AT E440960 T1 ATE440960 T1 AT E440960T1 AT 00906047 T AT00906047 T AT 00906047T AT 00906047 T AT00906047 T AT 00906047T AT E440960 T1 ATE440960 T1 AT E440960T1
Authority
AT
Austria
Prior art keywords
epitopes
helper cell
cell epitopes
sgrrqrrfagvvlagva
fagvvlagvalgvataa
Prior art date
Application number
AT00906047T
Other languages
English (en)
Inventor
David Jackson
Souravi Ghosh
John Walker
Original Assignee
Univ Melbourne
Csl Ltd
Commw Scient Ind Res Org
Queensland Inst Med Res
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP8533A external-priority patent/AUPP853399A0/en
Priority claimed from AUPQ2013A external-priority patent/AUPQ201399A0/en
Application filed by Univ Melbourne, Csl Ltd, Commw Scient Ind Res Org, Queensland Inst Med Res, Inst Medical W & E Hall filed Critical Univ Melbourne
Application granted granted Critical
Publication of ATE440960T1 publication Critical patent/ATE440960T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
AT00906047T 1999-02-05 2000-02-07 T-helferzellen-epitope ATE440960T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP8533A AUPP853399A0 (en) 1999-02-05 1999-02-05 T helper cell epitopes
AUPQ2013A AUPQ201399A0 (en) 1999-08-04 1999-08-04 T-helper cell epitopes
PCT/AU2000/000070 WO2000046390A1 (en) 1999-02-05 2000-02-07 T helper cell epitopes

Publications (1)

Publication Number Publication Date
ATE440960T1 true ATE440960T1 (de) 2009-09-15

Family

ID=25645983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906047T ATE440960T1 (de) 1999-02-05 2000-02-07 T-helferzellen-epitope

Country Status (15)

Country Link
US (5) US6685947B1 (de)
EP (2) EP2103691A1 (de)
JP (2) JP4699612B2 (de)
KR (2) KR100955668B1 (de)
AT (1) ATE440960T1 (de)
AU (1) AU765164B2 (de)
CA (1) CA2361658C (de)
CY (1) CY1109710T1 (de)
DE (1) DE60042816D1 (de)
DK (1) DK1147212T3 (de)
ES (1) ES2332701T3 (de)
NZ (1) NZ513482A (de)
PT (1) PT1147212E (de)
WO (1) WO2000046390A1 (de)
ZA (1) ZA200106413B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513482A (en) * 1999-02-05 2003-08-29 Univ Melbourne T helper cell epitodes derived from canine distemper virus for producing an immune response in an animal
US20050106137A1 (en) * 2000-05-05 2005-05-19 Stephen Grimes Chimeric peptide immunogens
US20030045467A1 (en) * 2001-01-05 2003-03-06 Tihamer Orban Autoantigen composition
AU2003249778B2 (en) 2002-08-12 2010-09-23 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
CN1688606B (zh) 2002-08-12 2013-12-25 昆士兰医学研究所理事会 含有辅助t细胞和b细胞表位的新的免疫原性脂肽
US7178491B2 (en) * 2003-06-05 2007-02-20 Caterpillar Inc Control system and method for engine valve actuator
US8354380B2 (en) 2004-06-17 2013-01-15 Mannkind Corporation NY-ESO-1 peptide analogs
WO2006026834A1 (en) 2004-09-10 2006-03-16 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated lhrh formulations
AU2005282231B2 (en) * 2004-09-10 2011-03-10 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated LHRH formulations
CN101448517A (zh) 2005-04-19 2009-06-03 伊莱利利公司 用于疾病免疫干预的单价和多价合成多糖抗原
BRPI0611390A2 (pt) * 2005-06-01 2010-09-08 Pfizer Prod Inc composições de vacina e uso de composições compreendendo vacina anti-lhrh na preparação de um medicamento para tratar incontinência urinária
SG162817A1 (en) 2005-06-17 2010-07-29 Mannkind Corp Methods and compositions.to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
BRPI0611793A2 (pt) * 2005-06-17 2009-01-13 Mannkind Corp anÁlogos de epÍtopo
WO2007127787A2 (en) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Insulin autoantigen-specific regulatory cd4+ t cells
CO2021017322A1 (es) * 2021-12-16 2023-06-20 Univ Cooperativa De Colombia Péptidos inmunogénicos contra el virus distemper canino (cdv)
CN115960262A (zh) * 2022-10-19 2023-04-14 四川农业大学 展示cdv抗原表位的犬细小病毒样颗粒及构建方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
JP2001513120A (ja) 1997-02-11 2001-08-28 ザ カウンシル オブ ザ クイーンズランド インスティチュート オブ メディカル リサーチ ペプチドを含むポリマー
NZ513482A (en) * 1999-02-05 2003-08-29 Univ Melbourne T helper cell epitodes derived from canine distemper virus for producing an immune response in an animal

Also Published As

Publication number Publication date
JP2002536384A (ja) 2002-10-29
US20070248615A1 (en) 2007-10-25
CA2361658C (en) 2013-04-09
US7097844B2 (en) 2006-08-29
EP2103691A1 (de) 2009-09-23
AU2783600A (en) 2000-08-25
WO2000046390A1 (en) 2000-08-10
KR100905264B1 (ko) 2009-06-29
DK1147212T3 (da) 2010-01-04
NZ513482A (en) 2003-08-29
KR100955668B1 (ko) 2010-05-06
KR20010101796A (ko) 2001-11-14
JP2011121965A (ja) 2011-06-23
CY1109710T1 (el) 2014-08-13
DE60042816D1 (de) 2009-10-08
US7241448B2 (en) 2007-07-10
EP1147212B1 (de) 2009-08-26
US6685947B1 (en) 2004-02-03
JP4699612B2 (ja) 2011-06-15
PT1147212E (pt) 2009-12-03
US7572454B2 (en) 2009-08-11
US7037507B2 (en) 2006-05-02
ZA200106413B (en) 2002-08-05
US20060199177A1 (en) 2006-09-07
US20050186220A1 (en) 2005-08-25
CA2361658A1 (en) 2000-08-10
ES2332701T3 (es) 2010-02-11
US20050037014A1 (en) 2005-02-17
EP1147212A4 (de) 2004-03-31
AU765164B2 (en) 2003-09-11
EP1147212A1 (de) 2001-10-24
KR20090015892A (ko) 2009-02-12

Similar Documents

Publication Publication Date Title
CY1109710T1 (el) Επιτοπα βοηθητικων τ λεμφοκυτταρων
TR199900267T2 (xx) GnRH-L�kotoksin kimeralar�.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
NO20002800D0 (no) Cyklosporinholdig mikroemulsjon, forkonsentratsammensetning
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
DK1353689T3 (da) Immuniseringspræparater og anvendelse deraf
DZ1835A1 (fr) Nouvelles formulations.
TR200000152T2 (tr) Yeni bileşikler.
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
ATE326237T1 (de) Miscmicellen aus lipopeptiden für induzierung einer immunantwort
DE60230456D1 (de) Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren
GB2301591A (en) Cytotoxic T-cell epitopes
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DE69840415D1 (de) Haemasterlin analoge
NO20073914L (no) Biologisk aktive peptider
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
DE69426121D1 (de) Gen grb3-3, variante und ihre verwendungen
NO971997D0 (no) Bruk av immunmodulerende midler
ATE386049T1 (de) Epstein-barr virus type b ctl epitopen
IL139604A0 (en) Novel peptides
ATE372787T1 (de) Atelocollagen enthaltende gen-zusammensetzungen
DE69836485D1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
ES2218796T3 (es) Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1147212

Country of ref document: EP